Woodcock: Maybe FDA Could Use 'Price' To Queue Generics, If HHS Defined 'Price Hike'

January 28, 2016 at 4:52 PM
FDA drug chief Janet Woodcock gave a small opening to the agency factoring drug price spikes in how it queues generic drug approvals, telling a Senate panel Thursday that such a policy might be possible if HHS came up with a “bullet proof” way of defining a price spike. Woodcock initially appeared to reject the notion when queried by Sen. Elizabeth Warren (D-MA) at a health committee hearing, but later indicated a potential opening to factor price spikes in agency...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.